344298-51-7 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-4-methoxy-3-pyridinecarboxylic acid methyl ester is used as an intermediate in the synthesis of clopidogrel for its antiplatelet and antithrombotic effects. It plays a vital role in the production of medications aimed at preventing blood clots in patients with a history of heart attack, stroke, or peripheral vascular disease.
Used in Cardiovascular Medications:
2-Chloro-4-methoxy-3-pyridinecarboxylic acid methyl ester is used as a precursor in the development of antiplatelet drugs for the treatment and prevention of cardiovascular conditions. Its contribution to the synthesis of clopidogrel makes it an essential component in medications that help manage the risk of blood clot formation in at-risk patients.
Check Digit Verification of cas no
The CAS Registry Mumber 344298-51-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,4,2,9 and 8 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 344298-51:
(8*3)+(7*4)+(6*4)+(5*2)+(4*9)+(3*8)+(2*5)+(1*1)=157
157 % 10 = 7
So 344298-51-7 is a valid CAS Registry Number.
344298-51-7Relevant articles and documents
HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS
-
Page/Page column 159, (2021/11/13)
Disclosed are heterocyclic heteroaromatic macrocyclic ether compounds, pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. Also disclosed are methods of treating or preventing cancer using the heterocyclic heteroaromatic macrocyclic ether compounds, pharmaceutically acceptable salts of the compounds, and pharmaceutical compositions thereof.
2-PYRIDYLOXY-3-ESTER-4-ETHER OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 37, (2015/06/25)
The present invention is directed to 2-pyridyloxy-3-ester-4-ether compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the 2-pyridyloxy-4-ether compounds described herein in the potential treatment or prev